Plasma Fractionation

Posted On 2018-01-03 02:54:52

Guest Editor: Thierry Burnouf, Professor, Director of the Graduate Institute of Biomedical Materials and Tissue Engineering, and of the International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei

Preface

Annals of Blood special issue on plasma fractionation
Thierry Burnouf

Review Article
An overview of plasma fractionation
Thierry Burnouf

Mini-Review

A global initiative on local preparation of viral inactivated cryoprecipitate in developing countries
Jean-Claude Faber

Role of the mini-pool cryoprecipitate technology for cost-saving and guarantee of local Factor VIII, Von Willebrand Factor and Fibrinogen product supply: Egypt experience
Magdy El Ekiaby, Thierry Burnouf, Hadi Goubran, Mirjana Radosevich, Ahmed El Ekiaby

Review Article

Regulation of plasma for fractionation in the United States
Mark Weinstein

Evidence-based clinical indications of plasma products and future prospects
Paul F. W. Strengers

Steps and challenges in the implementation of a plasma fractionation program: Brazil experience
Luiz Amorim

Building blocks of the viral safety margins of industrial plasma products
Thomas R. Kreil

The organization of transfusion and fractionation in France and its regulation
Françoise Rossi

Indian plasma fractionation industry: challenges and opportunities
Ranjeet S. Ajmani

Plasma fractionation in South Africa: challenges and successes in meeting international standards
Jeh-Han Omarjee, Willem Andreas Germishuizen, Rangini Chetty, David Stubbings


Disclosure:
The series “Plasma Fractionation” was commissioned by the editorial office, Annals of Blood without any sponsorship or funding. Thierry Burnouf served as the unpaid Guest Editor for the series.